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Abstract
Background: in recent years, an increasing interest in the application of selective embolization of
thyroid arteries (SETA) in the treatment of thyroid diseases is observed. In the present report, we
analyse the value, safety and possible indications for preresective SETA in cases of large toxic
goitres.
Patients and method: the study group comprised 10 patients with large toxic goitre (thyroid
volume 254 ± 50 mL), including one patient with cervicomediastinal goitre and one patient with
anti-thyroid drug intolerance in state of overt thyrotoxicosis. All the patients underwent SETA of
the superior and/or inferior thyroid arteries, followed by thyroidectomy, performed up to thirty-
six hours after SETA (23.1 ± 11 h). After embolization, selective angiographies of thyroid arteries
were performed to ensure that the targeted arteries had been completely occluded.
Results and conclusion: in all the patients, SETA decreased blood flow through the thyroid.
Preresective SETA reduced blood loss during and after thyroidectomy and decreased the operating
time, but the differences were too small to justify routine applications of preresective SETA as an
adjunct to surgical treatment of toxic goitre. On the other hand, SETA is a safe and minimally-
invasive technique, which may become an attractive option for quick preparation to surgery in
selected patients with toxic goitre, who present anti-thyroid drug intolerance or refuse radioactive
iodine treatment.
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Embolization of vascular tumours of the head, the neck
and the central nervous system (CNS) has become an
important adjunct to treatment of these pathologies. The
technique of selective embolization has extensively been
used to occlude vessels, either as an alternative to tradi-
tional therapy or when traditional therapy fails. Recently,
embolization techniques have been employed more com-
monly and with higher precision and facility. As a result,
this alternative technique has quickly evolved into the
first-line therapy for many complex clinical conditions,
surgical repairs of which are considered to bear high risk
of various degrees. The introduction of this procedure has
improved morbidity and mortality rates of patients with
tumours of the head, the neck and the central nervous sys-
tem, while also facilitating their removal [1,2]. The tech-
nological advances in microcatheters and new, safer
embolic agents have permitted a wider range of applica-
tions of this form of treatment. In spite of this, the
number of publications on the application of selective
embolization of thyroid arteries (SETA) in the treatment
of thyroid disorders is rather limited. The published
reports are limited to the applications of SETA in treat-
ment of thyrotoxicosis – particularly in Graves' disease [3-
5] – and thyroid cancer [6-8].
On the other hand, there are some reports on the effective
use of SETA in the treatment of vascular lesions of thyroid
arteries [9-12]. Also numerous studies have been per-
formed on embolization of metastases from thyroid carci-
nomas [13-16].
In the present report, we analyse the value of preresective
SETA, applied as an adjunct to surgical treatment of
selected cases of large toxic goitres. The aim of our study
was to define potential indications for the application of
preoperative SETA in the treatment of toxic goitre.
Patients and methods
Ten patients with toxic goitre of second degree (WHO
classification) were enrolled in the study from September
2003 to June 2006. In those patients, SETA was performed
as preresective therapy. The study protocol had been
approved by the Ethics Committee of the Medical Univer-
sity of Lodz. The patients were informed of the procedure
and of all the risks and potential side effects, associated
with it. Afterwards, they signed a consent form as their
agreement to undergo arterial embolization.
From the Department of Surgery files a group of 20
patients with toxic goitre were selected. The group was
age-, gender- and thyroid volume-matched with the group
of the patients that was thyroidectomised after SETA.
Groups were compared to assess whether there was any
difference in the operating time and blood loss between
the patients, thyroidectomised after preresective emboli-
zation and operated on without preresective emboliza-
tion.
Selective Embolization of Thyroid Arteries
The patients underwent SETA of the both superior and
one of the two inferior thyroid arteries. The procedure was
performed by a qualified team, using the Seldinger's tech-
nique [17]. A typical procedure required less than one
hour. In brief, the patient was placed in a supine position.
The inguinal pulsation point of either the left or the right
femoral artery was chosen as the puncture site. A small
skin incision was made under local anaesthesia (1% pro-
caine, 2–3 mL). The puncture needle, along with a can-
nula, was inserted into the femoral artery through the
incision. Next, the needle was removed, while the cannula
remained in the vessel lumen as an entry portal for a 4 or
5F-size angiographic catheter (Vertebral – Cordis, Europe
NV, the Netherlands and Multipurpose, Balton, Poland).
The catheter was advanced from the femoral artery via the
abdominal aorta and, sequentially, to both the superior
and one of the inferior thyroid arteries. Migration of the
catheter was visualised by a digital imaging x-ray device
(Angiorey DFP-50A, Toshiba, Japan). Before emboliza-
tion, a contrast medium (Ultravist 300; Schering AG, Ger-
many) was injected into the vessels, thus allowing us to
see the arteries and those regions of the thyroid to which
they supplied blood. Granules, consisting of polyvinyl
alcohol (PVA, Cordis Neurovascular Inc., Miami, USA),
ranging from 150 to 750 μm in size, were slowly injected
into the vessels. An additional step to embolize selected
arteries involved the use of a non-magnetic wire coil with
synthetic fibres (MReye® IMWCE 35-5-8, Cook, Denmark)
of appropriate size, depending on the lumen of the arter-
ies in question. After SETA, selective angiography of the
thyroid arteries – as digital subtraction angiography
(DSA) images – was performed to estimate the blood flow
through the gland and ensure complete occlusion of the
targeted arteries. Additionally, US-scans in all the patients
and CT-scans in selected patients were performed after the
embolization and before surgery, allowing to analyse
influence of SETA on thyroid volume and blood flow
through the gland.
Concentrations of free triiodothyronine (FT3), free 
thyroxine (FT4), thyrotropin (TSH), thyroglobulin (Tg), 
parathormone (PTH) and calcium (Ca++)
Tg, FT3, FT4, TSH, calcium, and PTH concentrations were
measured by the electrochemoluminescence (ECL)
method, using a Modular E170 (Roche) analyzer and
appropriate kits (Roche-Diagnostics).
Statistical analyses
Unpaired T-test was used to assess whether there was any
difference in the operating time and blood loss betweenPage 2 of 7
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after preresective embolization and the thyroid volume-
matched patients, thyroidectomised because of toxic goi-
tre without preresective embolization.
Results
In all the patients, thyroidectomy was performed before
the 36th hour after SETA. Nine patients demonstrated toxic
goitre at the stage of either euthyroidism or subclinical
hypothyroidism (Table 1). One of the above patient had
retrosternal goitre. In all the cases, SETA effectively limited
blood flow through the thyroid gland – confirmed in DSA
(Figures 1, 2, 3), CT scans (Figure 2) and US-scan. We ret-
rospectively compared the operations of investigated
patients with the twenty operations of toxic goitre of sim-
ilar volume, performed without prior preresective SETA
(patient were not randomized). The application of SETA
significantly shortened the operating time and reduced
drainage and blood loss during thyroidectomy (Table 2).
On the other hand, preresective SETA had no influence on
the rate of complications. No major complications were
observed, except haematoma (2 cases), fever (2 cases) and
neck pain (2 cases).
The patient number ten was a 75-year old female, suffer-
ing from depressive syndrome (Figure 3). She was trans-
ferred to our Department from the Endocrinology
Department because of large toxic goitre, compressing the
trachea. She was treated with antithyroid drugs, however,
because of agranulocytosis, the treatment was stopped
and, on admission to the Department of Surgery, she was
in the course of ineffective treatment with lithium carbon-
ate. In spite of evident indications to surgery, the patient
was overly thyrotoxic (TSH <0.001 mIU/mL, FT4 237.27
pmol/L, FT3 18.01 pmol/L). Since the clinical condition
of the patient was aggravating, with developing respira-
tory insufficiency, a decision was taken to perform pre-
resective selective embolization of thyroid arteries, to be
followed by immediate thyroidectomy. No significant
bleeding was observed during that operation, after which,
immediate amelioration was observed. The patient was
discharged from the department of surgery on the 4th day
after the applied procedures.
Discussion
Although the generally accepted therapies of toxic goitres
are very effective in alleviating hyperthyroidism and/or
thyroid ablation, there still remain some difficult cases
that are not amenable to current therapeutic options. In
2002, Xiao et al. [3] proposed arterial embolization as a
novel approach to thyroid ablative therapy. The authors
performed selective arteriography, using Seldinger's tech-
nique [17], followed by embolization of thyroid arteries
in 22 patients with Graves' disease. From that group, 14
patients remained euthyroid after SETA, 6 were operated
on because of goitre and the other two needed a mainte-
nance dose of antithyroid drug therapy [3]. A similar
study was performed by Zhao et al. [4] on 28 patients with
Graves' disease. From that group of patients, 22 became
euthyroid, five improved and one demonstrated tempo-
rary improvement, followed by recurrence of the disease.
Both groups of investigators did not observe any serious
complications in any of those patients and, after a follow-
up period, ranging from 12 to 24 months, they considered
the procedure to be effective, minimally invasive and safe
[3,4]. Interestingly enough, Zhao et al. [4] noted an
increase of thyroid hormones together with a drop in TSH
concentration on the third day after the embolization pro-
Patient No 2: State before (on the left) and after (in the middle) embolization of the right superior thyroid artery (lateral view), and 16W angio CT-scan with 3D r construc ion 24- ours after SETA (on the right)Figure 1
Patient No 2: State before (on the left) and after (in the middle) embolization of the right superior thyroid 
artery (lateral view), and 16W angio CT-scan with 3D reconstruction 24-hours after SETA (on the right).Page 3 of 7
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patients with differentiated thyroid cancer [8]. Moreover,
we observed a massive increase of thyroglobulin concen-
trations and a moderate increase of free thyroid hor-
mones, together with a fall of TSH concentration after 48
hours from SETA. In our opinion, it resulted from
ischemic necrosis of the thyroid gland. Although, SETA
reduces thyroid blood supply, the veins are not closed,
and blood outflow remains unconstrained. In conse-
quence, colloid from dying thyrocytes (comprising Tg, T3,
T4 and, probably, other biochemical compounds) gets
into circulation. This creates a potential risk of thyrotoxi-
cosis aggravation, which may be particularly important in
elderly people with ischemic heart disease and/or serious
arrhythmia. Moreover, the review of the literature did not
help us elucidate any potential consequences of increased
serum Tg concentration. However, in one earlier study, its
authors described embolization of DTC metastases to
have caused massive Tg increase, which – probably –
resulted in adult respiratory distress syndrome [18]. Con-
sidering the above observation, we suggested thyroidec-
tomy to be performed till the 36th hour after preresective
Patient No 5: CT scan showing trachea compression (on the left) and state before (in the middle) and after SETA of the left inferior thyroid artery (on the right)Figure 2
Patient No 5: CT scan showing trachea compression (on the left) and state before (in the middle) and after 
SETA of the left inferior thyroid artery (on the right).
Patient No 10: photo of the patient before the procedures (on the left), state after embolization of the right superior and right inferior thyroid arteries and during arteriography of the left inferior artery (in th  middle), s ate after embolization of thesup rior and both inferior thyroid arteries, during arteriography f the left superior thyroid rtery (on the right) – the artery was t embolized becaus  of he communication with the left sub ingual rteryFigu e 3
Patient No 10: photo of the patient before the procedures (on the left), state after embolization of the right 
superior and right inferior thyroid arteries and during arteriography of the left inferior artery (in the middle), 
state after embolization of the right superior and both inferior thyroid arteries, during arteriography of the 
left superior thyroid artery (on the right) – the artery was not embolized because of the communication with 
the left sublingual artery.Page 4 of 7
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significant increase in concentrations of the parameters in
question [9].
Tartaglia et al. [5] also observed the increased thyroid hor-
mones concentrations after embolization of cervicomedi-
astinal hyperfunctioning goitre, 7 days after SETA. The
goal of preresective embolization in their case was thyroid
volume reduction. The authors succeeded, observing
shrinkage of the thyroid gland by half of its initial volume
[5]. A similar reduction of thyroid volume (from one third
to one half of initial volume) was observed by Xiao et al.
[3]. Neither we, nor Ramos et al., observed any significant
reduction of thyroid volume after SETA [7,8]. However, as
mentioned above, thyroidectomy was performed in the
reported study up to the 36th hour after SETA, and up to
the sixth day after SETA in our previous study and in the
study and the study described by Ramos et al. [7]. In the
present group, the patient with retrosternal goitre was suc-
cessfully operated through cervical incision after SETA.
Comparing with retrospectively analysed patients, oper-
ated because of similar goitre, the patient was expected to














1 65 240 0.45 4.33 12.90 28
2 47 230 1.27 3.76 11.15 32
3 70 215 2.16 4.57 10.30 24
4 67 210 3.68 3.78 14.46 26
5 71 220 2.48 3.25 10.89 28
6 58 250 4.16 3.12 10.42 36
7 49 248 1.86 4.10 15.16 6
8 57 285 2.46 4.27 11.86 26
9 70 260 0.98 3.12 10.12 24
10 75 380 > 0.001 18.01 237.27 1
Normal values: TSH – 0.27–4.2 mU/L; FT3 – 3.95 – 6.8 pmol/L; FT4 – 12–22 pmol/L.
*Tx-thyroidectomy
Table 2: Comparison of selected parameters of thyroidectomies performed with and without preresective SETA. 
Thyroidectomy with preresective
SETA (N = 9)
Thyroidectomy without preresective SETA
(N = 20)
p
Operating time [min] 98 ± 35 135 ± 25 < 0.01
Blood loss [g] 60 ± 12 90 ± 26 < 0.01







Blood loss was calculated as difference between gauze weight before and after operation.Page 5 of 7
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changes in thyroid volume were observed, we noted struc-
tural changes in the gland, which may have been respon-
sible for the differences in its consistency, facilitating
tumour removal. On the other hand, neither major nor
even minor bleeding allowed performing radical manoeu-
vres, which could have accelerated the operation, and may
have resulted in resection of the gland through cervical
incision only.
The goal of SETA application in the present study was to
decrease blood flow through a significant volume of thy-
roid tissue. Thus, decreased vascularization of thyroid tis-
sue facilitated the removal of tumour, reducing blood loss
and shortening the operation time. From the technical
point of view, all the procedures were successful, effec-
tively suppressing blood flow through the gland and
resulting in a much smaller blood loss during thyroidec-
tomy, decreased drainage and shortened operation time,
although there was no difference in the rate of complica-
tions. On the other hand, the above mentioned differ-
ences were too small to justify routine applications of
SETA as a pre-treatment method, even in cases of large
toxic goitres. Preoperative SETA may potentially limit the
risk of damaging the surrounding tissues, including the
oesophagus, the parathyroid gland and recurrent laryn-
geal nerve. However, Tarttiglia et al. [5] reported, 30 days
after SETA, a tight lesion and fibrous reaction and infiltra-
tion of giant multinucleate cells, probably caused by
postembolization thyroiditis, that may have resulted in
difficult recurrent laryngeal nerve preparation. Similar
histological observations were described in the series by
Xiao et al. [3].
The course of the treatment, applied to patient number
ten, indicates potential values of SETA in quick prepara-
tion to surgery of patients with large toxic goitre and intol-
erance to anti-thyroid drugs (ATD) treatment. The patient
was operated on in state of overt thyrotoxicosis. However,
it should be underlined that the applied preresective SETA
was followed by immediate thyroidectomy because of
worsening respiratory insufficiency. Although the results
of the treatment were excellent, the application of SETA as
a pre-treatment to surgery in thyrotoxic patients with large
goitres may only be recommended as the "last resort'
treatment. On the other hand, recently Zhao et al. [19]
published a case report of the patient with thyrotoxic crisis
successfully cured with SETA. Unfortunately, considering
the fact that similar patients are rarely seen in the day-to-
day practice, no larger series of similar patients are likely
to be investigated.
Conclusion
Preresective SETA is a safe and minimally-invasive tech-
nique that decreases operating time and blood flow
through the thyroid, minimalizing blood loss during and
after thyroidectomy. This procedure may become an
attractive option for quick preparation to surgery in
selected patients with toxic goitre, who present ATD intol-
erance or refuse radioactive iodine (131I) treatment.
Although, SETA may be an useful adjunct to surgery in
selected cases of toxic goitres, it cannot be recommended
as a routine treatment.
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